Evaluate Sunosi ® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
Conditions: Narcolepsy; Obstructive Sleep Apnea; Excessive Daytime Somnolence; Excessive Sleepiness; Postpartum Intervention: Drug: Solriamfetol 150 mg Oral Tablet Sponsor: Jazz Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2021 Category: Research Source Type: clinical trials